A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Ahmed, Zahoor
Neupane, Karun
Ashraf, Rabia
Khan, Amna
Shahzad, Moazzam
Farooqui, Arafat Ali
Faisal, Muhammad Salman
Nabeel, Shaha
Jamil, Abdur Rehman
Anwer, Faiz
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials
    Neupane, Karun
    Ahmed, Zahoor
    Khan, Amna
    Ashraf, Rabia
    Shahzad, Moazzam
    Nabeel, Shaha
    Akbar, Arshia
    Javed, Saad
    Abdullah, Syed Maaz
    Faizan, Unaiza
    Anwer, Faiz
    BLOOD, 2020, 136
  • [2] Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis
    Ahmed, Zahoor
    Neupane, Karun
    Ashraf, Rabia
    Khan, Amna
    Shahzad, Moazzam
    Faisal, Muhammad Salman
    Khan, Sana Irfan
    Rafae, Abdul
    Akbar, Arshia
    Wahab, Ahsan
    Ehsan, Hamid
    Anwer, Faiz
    BLOOD, 2020, 136
  • [3] Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma
    Neupane, Karun
    Ahmed, Zahoor
    Ashraf, Rabia
    Khan, Amna
    Shahzad, Moazzam
    Farooqui, Arafat Ali
    Faisal, Muhammad Salman
    Abdullah, Syed Maaz
    Kashyap, Richi
    Ehsan, Hamid
    Anwer, Faiz
    BLOOD, 2020, 136
  • [4] Efficacy of Upfront Daratumumab Combination Regimen in Patients with Newly Diagnosed Multiple Myeloma
    Thein, Kyaw Zin
    Htut, Thura Win
    Win, Myint Aung
    Swarup, Sriman
    Sultan, Anita
    Ball, Somedeb
    Phyu, Ei Moe
    Tun, Aung M.
    Pandey, Ramesh
    Han, Myat Min
    Hardwicke, Fred
    Tijani, Lukman
    D'Cunha, Nicholas
    Quick, Donald P.
    BLOOD, 2019, 134
  • [5] Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta-analysis
    Xu, Wenjun
    Li, DianFang
    Sun, Yanhua
    Ran, Xuehong
    Wang, Baohong
    Wu, Wei
    Sheng, Zhixin
    Liu, Liping
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (06) : 542 - 551
  • [6] A new standard of care in newly diagnosed multiple myeloma
    Richardson, Paul G.
    LANCET, 2010, 376 (9758): : 2043 - 2044
  • [7] Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis
    Ahmed, Zahoor
    Neupane, Karun
    Ashraf, Rabia
    Khan, Amna
    Rafae, Abdul
    Shahzad, Moazzam
    Farooqi, Muhammad Saad
    Ali, Sundas
    Javed, Saad
    Kashyap, Richi
    Nabeel, Shaha
    Anwer, Faiz
    BLOOD, 2020, 136
  • [8] Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review
    Ali, Mohammad O.
    Abdullah, Hafez M.
    Obeidat, Khaldun
    Chakraborty, Rajshekhar
    Al Hadidi, Samer
    EJHAEM, 2023, 4 (03): : 719 - 722
  • [9] Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta of Phase III Randomized Controlled Trials
    Aboaid, Hazem
    Srinivasmurthy, Ramaditya
    Jones, Daniel Thomas
    Nguyen, Kevin
    Nanda, Rishi Kumar
    Thein, Kyaw Zin
    Htut, Thura Win
    BLOOD, 2024, 144 : 7036 - 7037
  • [10] Addition of Daratumumab to Drug Regimens in the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Aiman, Wajeeha
    Anwar, Ayesha
    Satti, Danish Iltaf
    Hamza, Mohammad
    Perez, Alynna Mariz
    Khan, Arslan Ahmad
    Nepal, Ashish
    Supraja, A.
    Yeesau, Mariam
    Nanjundaiah, Nikhilesh
    Kaleem, Muhammad Shaarif
    Avula, Sreekant
    Dewan, Sandesh
    Kosach, Sviatoslav
    Tarrar, Talha Azam
    Suleman, Muhammad
    Ali, Muhammad Ashar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S405 - S405
12345